Literature DB >> 35462470

Research progress on the relationship between chronic periodontitis and Parkinson's disease.

Mengyao Bian1, Lili Chen1, Lihong Lei1.   

Abstract

Chronic periodontitis is an infectious disease, which has a reciprocal relationship with a variety of systemic disorders. Parkinson's disease is a prevalent neurodegenerative disease in which inflammation plays an important role for its progression. A vast number of studies suggest that there is a potential connection between chronic periodontitis and neurodegenerative diseases such as Parkinson's disease. Individuals with Parkinson's disease usually have poor periodontal health, and their oral flora composition differs from that of healthy people; at the same time, patients with chronic periodontitis have a higher risk of Parkinson's disease, which can be reduced with regular periodontal treatment. In fact, the mechanism of interaction between chronic periodontitis and Parkinson's disease is not clear. According to several studies, the clinical symptoms of Parkinson's disease prevent patients to maintain oral hygiene effectively, increasing the risk of periodontitis. Neuroinflammation mediated by microglia may be the key to the influence of chronic periodontitis on Parkinson's disease. Periodontal pathogens and inflammatory mediators may enter the brain and activate microglia in various ways, and ultimately leading to occurrence and development of Parkinson's disease. This article reviews the recent research progress on the association between chronic periodontitis and Parkinson's disease, and its potential mechanism to provide information for further research.

Entities:  

Keywords:  Chronic periodontitis; Microglia; Neuroinflammation; Parkinson’s disease; Periodontal bacteria; Review

Mesh:

Year:  2021        PMID: 35462470      PMCID: PMC9109767          DOI: 10.3724/zdxbyxb-2021-0111

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  55 in total

1.  Caries and periodontal disease in patients with Parkinson's disease.

Authors:  Thomas Müller; Romuald Palluch; Jochen Jackowski
Journal:  Spec Care Dentist       Date:  2011 Sep-Oct

Review 2.  The sensory circumventricular organs: brain targets for circulating signals controlling ingestive behavior.

Authors:  Mark Fry; Alastair V Ferguson
Journal:  Physiol Behav       Date:  2007-04-12

3.  Striatal blood-brain barrier permeability in Parkinson's disease.

Authors:  Madison T Gray; John M Woulfe
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-11       Impact factor: 6.200

4.  Orofacial function and oral health in patients with Parkinson's disease.

Authors:  Merete Bakke; Stine L Larsen; Caroline Lautrup; Merete Karlsborg
Journal:  Eur J Oral Sci       Date:  2011-02       Impact factor: 2.612

Review 5.  Can oral microbial infections be a risk factor for neurodegeneration? A review of the literature.

Authors:  Rajeev Ranjan; Arra Abhinay; Monalisa Mishra
Journal:  Neurol India       Date:  2018 Mar-Apr       Impact factor: 2.117

6.  Increased frequencies of caries, periodontal disease and tooth loss in patients with Parkinson's disease.

Authors:  Ayumi Hanaoka; Kenichi Kashihara
Journal:  J Clin Neurosci       Date:  2009-06-30       Impact factor: 1.961

Review 7.  Inflammatory response in Parkinson's disease (Review).

Authors:  Junqiang Yan; Qizhi Fu; Liniu Cheng; Mingming Zhai; Wenjuan Wu; Lina Huang; Ganqin Du
Journal:  Mol Med Rep       Date:  2014-09-12       Impact factor: 2.952

Review 8.  The Possible Causal Link of Periodontitis to Neuropsychiatric Disorders: More Than Psychosocial Mechanisms.

Authors:  Sadayuki Hashioka; Ken Inoue; Tsuyoshi Miyaoka; Maiko Hayashida; Rei Wake; Arata Oh-Nishi; Masatoshi Inagaki
Journal:  Int J Mol Sci       Date:  2019-07-30       Impact factor: 5.923

9.  Leptomeningeal cells transduce peripheral macrophages inflammatory signal to microglia in reponse to Porphyromonas gingivalis LPS.

Authors:  Yicong Liu; Zhou Wu; Xinwen Zhang; Junjun Ni; Weixian Yu; Yanmin Zhou; Hiroshi Nakanishi
Journal:  Mediators Inflamm       Date:  2013-12-02       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.